University Hospital Tuebingen
4 clinical trials · 4 recruiting · OTHER
Trials by University Hospital Tuebingen
RECRUITINGPhase 1NCT05646550
Antibody CC-1 in Men With Biochemical Recurrence of Prostate Cancer
This trial is a phase I open-label, single center study designed to evaluate the safety, tolerability and preliminary efficacy of the bispecific prostate specific membrane antigen...
Sponsor: University Hospital TuebingenEnrolling: 561 location
Prostate Cancer Recurrent
RECRUITINGNCT07132333
Molecular Inflammation Board at the Center for Personalized Medicine
Molecular Inflammation Board at the Center for Personalized Medicine
Sponsor: University Hospital TuebingenEnrolling: 30001 location
Psoriasis (PsO)Psoriasis ArthritisInflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)+1
RECRUITINGNCT06487832
Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness
The overarching goal of the current study is to investigate the effect of GLP-1 on brain insulin responsiveness in a randomized, single-blinded, within subject cross-over study...
Sponsor: University Hospital TuebingenEnrolling: 601 location
Normal WeightOverweight and ObesityInsulin Sensitivity+1
RECRUITINGNCT06323772
Natural History Study in Patients with PDE6A-, PDE6B- and RHO-linked Retinitis Pigmentosa
The aim of the study is to apply a novel clinical investigation protocol in patients with Phosphodiesterase 6A (PDE6A), PDE6B and Rhodopsin (RHO)-based retinitis pigmentosa. This...
Sponsor: University Hospital TuebingenEnrolling: 401 location
Retinitis Pigmentosa